| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 29.140.153 $ | 99,88 | 376.138 | |||||||
| Johnson & Johnson | Johnson & Johnson COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 2.173.805 $ | 7,45 | 8.893 | |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb Company COM | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 2.148.344 $ | 7,36 | 35.422 | |
| Merck & Co., Inc | Merck & Co., Inc COM | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 2.146.334 $ | 7,36 | 17.843 | |
| AbbVie Inc. | AbbVie Inc. COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 2.070.505 $ | 7,10 | 9.520 | |
| Eli Lilly & Co. | Eli Lilly & Co. COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 1.931.517 $ | 6,62 | 2.100 | |
| Pfizer Inc. | Pfizer Inc. COM | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 1.121.824 $ | 3,85 | 39.951 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.091.740 $ | 3,74 | 1.413 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.055.797 $ | 3,62 | 5.759 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.033.568 $ | 3,54 | 7.416 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. COM | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 1.018.303 $ | 3,49 | 4.819 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.001.365 $ | 3,43 | 2.846 | |
| Viatris Inc | Viatris Inc COM | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 999.591 $ | 3,43 | 73.989 | |
| Zoetis Inc. | Zoetis Inc. CL A | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 996.037 $ | 3,41 | 8.426 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 992.658 $ | 3,40 | 2.223 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 966.557 $ | 3,31 | 1.630 | |
| Incyte Corporation. | Incyte Corporation. COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 644.063 $ | 2,21 | 6.843 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC SHS USD | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 632.750 $ | 2,17 | 3.347 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 450.762 $ | 1,55 | 3.657 | |
| Exelixis, Inc. | Exelixis, Inc. COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 440.866 $ | 1,51 | 10.279 | |
| Medpace Holdings Inc. | Medpace Holdings Inc. COM | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 415.364 $ | 1,42 | 865 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 371.240 $ | 1,27 | 5.449 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. COM | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 366.908 $ | 1,26 | 2.127 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 356.904 $ | 1,22 | 6.318 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 346.476 $ | 1,19 | 2.630 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 323.473 $ | 1,11 | 5.005 | |
| Alkermes PLC | Alkermes PLC SHS | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 296.317 $ | 1,02 | 8.380 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc COM | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 261.435 $ | 0,90 | 10.925 | |
| Spyre Therapeutics Inc | Spyre Therapeutics Inc COM NEW | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 178.205 $ | 0,61 | 3.533 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc COM | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 173.910 $ | 0,60 | 1.650 | |
| TG Therapeutics Inc | TG Therapeutics Inc COM | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 167.728 $ | 0,57 | 5.049 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 163.710 $ | 0,56 | 2.611 | |
| Catalyst Pharmaceuticals Inc. | Catalyst Pharmaceuticals Inc. COM | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 162.995 $ | 0,56 | 6.583 | |
| Amneal Pharmaceuticals Inc | Amneal Pharmaceuticals Inc COM STK CL A | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 161.391 $ | 0,55 | 12.984 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences Inc. COM | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 161.114 $ | 0,55 | 7.459 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation COM | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 153.870 $ | 0,53 | 3.238 | |
| Ligand Pharmaceuticals Incorporated | Ligand Pharmaceuticals Incorporated COM NEW | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 152.932 $ | 0,52 | 766 | |
| Mirum Pharmaceuticals Inc. | Mirum Pharmaceuticals Inc. COM | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 152.057 $ | 0,52 | 1.646 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 151.521 $ | 0,52 | 5.100 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 150.877 $ | 0,52 | 456 | |
| Guardant Health Inc | Guardant Health Inc COM | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 149.455 $ | 0,51 | 1.618 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 145.425 $ | 0,50 | 5.250 | |
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 144.069 $ | 0,49 | 2.836 | |
| Supernus Pharmaceuticals, Inc | Supernus Pharmaceuticals, Inc COM | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 143.491 $ | 0,49 | 2.776 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 142.334 $ | 0,49 | 551 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals Inc COM | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 141.142 $ | 0,48 | 2.012 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 140.568 $ | 0,48 | 1.872 | |
| 10X Genomics Inc | 10X Genomics Inc CL A COM | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 139.927 $ | 0,48 | 6.591 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 138.511 $ | 0,47 | 1.663 | |
| Acadia Pharmaceuticals Inc | Acadia Pharmaceuticals Inc COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 137.700 $ | 0,47 | 6.186 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics Inc. COM | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 132.713 $ | 0,45 | 5.633 | |
| 29.140.153 $ | 99,88 | 376.138 |